Objective: We have previously described placental oxygenation capacity as an index of placental function. The aim of this study was to utilize this test to evaluate placental gas exchange capacity in pre-eclampsia and fetal growth restriction (FGR). Study design: Two nested case-control studies were conducted between: (i) pre-eclamptic appropriate-forgestational-age fetus (AGA) and non-pre-eclamptic AGA; and (ii) pre-eclamptic FGR and non-pre-eclamptic FGR based on gestational age match. Umbilical A-V gas differences were compared between groups. Results: Pre-eclamptic AGA was associated with smaller A-V pO 2 and A-V pCO 2 differences compared to non-preeclampsia (A-V pO 2 , 7.1"3.8 mm Hg vs. 11.3"5.9 mm Hg, Ps0.001; A-V pCO 2 , 7.8"5.7 mm Hg vs. 10.7" 5.9 mm Hg, Ps0.01). Pre-eclamptic FGR was associated with smaller A-V pO 2 and A-V pCO 2 differences compared to non-pre-eclampsia (A-V pO 2 , 6.6"3.1 mm Hg vs. 10.8"8.1 mm Hg, P-0.001; 6.7"4.5 mm Hg vs. 10.9"10.3 mm Hg, Ps0.044). Pre-eclamptic FGR also had significantly lower venous pO 2 but not arterial pO 2 (Venous pO 2 , 20.3"6.3 mm Hg vs. 25.4"11.9 mm Hg, Ps0.003). 
Introduction
The placenta is the nutrient and gas exchange organ between mother and fetus. The adequacy of gas exchange is related to maternal placental perfusion and the adequacy of uptake is related to fetal perfusion and ramification of the villous tissue. We have previously described an index of placental function in terms of placental oxygenation capacity (umblical arterial-venous oxygen difference, or A-V pO 2 difference) w9x. In the study, the placenta had constant oxygenation throughout pregnancy, independent from gestational age, birth weight, duration of labor, and mode of delivery.
Since pre-eclampsia is frequently associated with shallow placentation caused by inadequate trophoblast invasion into the maternal spiral artery w4, 6, 7, 13x, it might be a model for abnormalities in the maternal compartment. Fetal growth restriction (FGR) on the other hand is frequently associated with umbilical blood flow abnormalities and decreased oxygen availability w12x, and therefore, serves as a model of abnormalities in the fetal compartment.
The aim of the study is to evaluate the impacts of maternal, fetal, and placental dysfunction on placental oxygenation capacity.
Patients and methods
Nested case-control studies were conducted using arterial and venous umbilical cord blood data recorded as part of a multicenter observational study of growth restricted fetuses. An additional set of patients was ascertained from our prospectively maintained perinatal database. Only singleton pregnancies delivered by pre-labor cesarean delivery were included. Excluded were also patients with fetal anomalies, placental abruption, umbilical cord prolapse, uterine rupture, and bleeding placenta previa.
The abstracted data included presence or absence of preeclampsia, gestational age at delivery, mode of delivery, indication of delivery, anesthesia at delivery, Apgar scores, infant weight with birth weight percentile, and the results of umbilical cord arterial and venous blood gasses. Umbilical cord blood gasses include pH, pO 2 , pCO 2 , , and base excess. The -HCO 3 crude A-V pO 2 and pCO 2 differences were calculated and were expressed as absolute values w9x. Pre-eclampsia was defined as a sustained blood pressure G140/90 mm Hg with proteinuria G300 mg from a 24-h urine collection or G1q, after 20 weeks of gestation w16x. FGR was defined as the birth weight below the 10 th percentile of gestational age in association with abnormal umbilical artery Doppler index w1x.
Two nested studies were conducted between: (i) pre-eclamptic patients with an appropriate-for-gestational-age fetus (AGA) and non-pre-eclamptic AGA; and (ii) pre-eclamptic FGR and non-pre-eclamptic FGR. Patients were matched by gestational age at delivery.
Continuous variables were analyzed by Mann-Whitney U-test and mean"SD or median with interquartile range, as appropriate. Pearson's correlation analysis and regression analysis with 95% individual prediction interval were used as appropriate. Two-tailed tests with P-0.05 were considered significant. The statistical significance was determined using Statistical Package for Social Scientists software (SPSS, Inc., version 12.0, Chicago, IL). The study protocol was approved by the Institutional Review Board (IRB) at the University of Maryland School of Medicine.
Results
Three hundred and seventy-nine patients were evaluated: 138 (36.4%) of non-pre-eclamptic AGA, 114 (30.1%) of pre-eclamptic FGR, 80 (21.1%) of non-pre-eclamptic FGR, and 47 (12.4%) of pre-eclamptic AGA. Due to these proportions, one-to-two ratio gestational age based match was performed between pre-eclamptic AGA and non-pre-eclamptic AGA (post-hoc analysis).
Pre-eclampsia vs. non-pre-eclampsia in AGA
Patient characteristics and umbilical cord gas analyses are shown in Table 1 . Mean gestational age in both groups was 30.4"3.6 weeks. The proportions of type of anesthesia were similar in the two groups (general anesthesia, pre-eclampsia vs. non-pre-eclampsia, 45.2% vs. 28.6%, Ps0.16). Umbilical arterial pO 2 in pre-eclampsia was similar to non-pre-eclamptics (13.9"6.7 mm Hg vs. 15.3"6.5 mm Hg, Ps0.29) whereas significantly smaller venous pO 2 return was seen in pre-eclampsia compared to non-pre-eclampsia (21.0"5.9 mm Hg vs. 26.6"8.1 mm Hg, Ps0.001). Accordingly, oxygenation capacity in pre-eclamptic placenta, the A-V pO 2 difference, was significantly smaller than in the non-pre-eclamptic placenta: 7.1"3.8 mm Hg vs. 11.3"5.9 mm Hg, Ps0.001. Placental oxygen supply was constant during pregnancy ( Figure 1) . Pre-eclamptic patients showed smaller distribution of oxygenation compared to non-pre-eclampsia. Pre-eclamptic patients also had smaller carbon dioxide clearance: A-V pCO 2 difference, 7.8"5.7 mm Hg vs. 10.7"5.9 mm Hg, Ps0.01 (Table 1) . Throughout pregnancy, A-V pCO 2 difference in pre-eclampsia was smaller (Figure 2 ).
Pre-eclampsia vs. non-pre-eclampsia in FGR
Placental oxygenation capacity was evaluated between pre-eclamptic FGR and non-pre-eclamptic FGR (Table 2) . Mean gestational age in the two groups was 30.2"3.0 weeks. The proportions of type of anesthesia were similar in the two groups (general anesthesia, pre-eclampsia vs. non-pre-eclampsia, 34.5% vs. 42.6%, Ps0.42). Placental oxygenation capacity in pre-eclamptic FGR was significantly decreased compared to non-pre-eclamptic FGR (6.6"3.1 mm Hg vs. 11.4"8.0 mm Hg, P-0.001).
This was supported by significantly smaller oxygenated venous return seen in pre-eclampsia whereas similar arterial oxygen tension were seen in both groups: venous pO 2 , 20.3"6.3 mm Hg vs. 25.4"11.9 mm Hg, Ps0.003; arterial pO 2 , 13.7"5.4 mm Hg vs. 14.5"7.9 mm Hg, Ps0.97. The A-V pCO 2 difference in pre-eclamptic FGR was smaller than in non-pre-eclamptic women (6.7"4.5 mm Hg vs. 10.9"10.3 mm Hg, Ps0.044). Placental oxygen supply in FGR was constant during pregnancy ( Figure 3 ). Pre-eclamptic FGR pregnancies showed smaller distribution of oxygenation compared to non-pre-eclamptics. A-V pO 2 difference between pre-eclampsia with AGA fetus and pre-eclampsia with FGR fetus appears similar (Figure 4 ).
Figure 4
Pre-eclampsia and arteriovenous pO 2 and pCO 2 difference. Pre-eclampsia decreases placental gas exchange capacity. PIHspre-eclampsia; AGAsappropriate-for-gestational-age; IUGRsintrauterine growth retardation. *Ps0.001 (compared to non-PIH AGA), **P-0.001 (compared to non-PIH FGR), qPs0.01 (compared to non-PIH AGA), qqPs0.044 (compared to non-PIH FGR).
Discussion
Umbilical arterial-venous gas difference was recently described to evaluate the placental respiratory function w9x. Placental oxygenation capacity remained steady through pregnancy w9x. This new approach of placental respiratory function was applied in this study to evaluate the effects of placental dysfunction using pre-eclampsia and FGR as models of abnormal placentation in the maternal and fetal compartments, respectively.
Our results suggest that pre-eclampsia is associated with decreased placental gas exchange capacity irrespective of the fetal growth pattern. Surprisingly, similar placental gas exchange capacity was observed between AGA and FGR fetuses in pre-eclamptic women. Several observations require further elaboration.
Pre-eclampsia decreases placental gas exchange. This is consistent with the shallow placentataion theory as a pathophysiologic basis of pre-eclampsia w4, 6, 7, 13x. With normal placentation, the cytotrophoblast invades into the maternal spiral artery within the endometrium to obtain higher oxygen content. With the invasion of the trophoblast, the spiral arteries are transformed from high resistance vessels into larger vessels with low resistance. This vessel remodeling is completed by 18-20 weeks of gestation w4, 13x. Trophoblast differentiation is normal under normal arterial oxygen tension, but continues proliferating under low oxygen tension w3x. Abnormal trophoblast invasion of the spiral arteries, such as in preeclampsia, leads to hypoxic trophoblast cells. Hypoxic stress alters placental villous angiogenesis, which leads to a poorly developed fetoplacental vasculature w5, 11x. The transfer of oxygen from mother to fetus is limited by blood-flow through the intervillous space w8x. Thus, in pre-eclampsia, the suboptimal placental nutrition and oxygenation predisposes to placental insufficiency and inadequate uteroplacental perfusion w2, 14x.
Whether the decreased gas exchange is the chronic in-utero manifestation in pre-eclampsia or is the terminal phenomenon secondary to placental inflammation such as neutrophil accumulation and activation needs further investigation. Increased placental anti-angiogenic factors far prior to the clinically evident pre-eclampsia w6x or increased neutrophil distribution in placentation phase of pre-eclampsia w10x may suggest that the decreased placental gas exchange may be the long-term in utero event seen in pre-clinical stages of pre-eclampsia.
FGR is one of the severe clinical complications of preeclampsia. Decreased oxygen availability is reported as the cause of FGR w12x. Thus, FGR with pre-eclampsia increases the risk for decreased oxygenation capacity compared to FGR in non-pre-eclamptics. Interestingly, pre-eclamptic FGR pregnancies showed lower umbilical A-V pO 2 differences and lower umbilical venous oxygen tension than non-pre-eclamptic FGR pregnancies (Table  2) , without difference in umbilical arterial oxygen tension in both groups. This implies that the placenta of preeclamptic FGR pregnancies has lower oxygenation capacity than non-pre-eclamptic FGR, and thus the umbilical venous return supplies lower oxygen tension to the fetus potentially contributing to the genesis of FGR. Decreased placental oxygenation capacity is character-istic of the FGR in pre-eclampsia. However, to our surprise, A-V pO 2 difference between pre-eclampsia with AGA fetus and pre-eclampsia with FGR fetus seems similar (Figure 4 ). This is possibly explained by delivery prior to clinical deterioration of the fetal condition or for maternal indications irrespective of fetal status. In either case, fetal acid-base status may not yet have been affected. Further study into the rate of clinical progression of pre-eclamptic and non-pre-eclamptic FGR pregnancies is necessary to clarify these observations.
It is possible that more pre-eclamptic women were delivered by cesarean section under general anesthesia than non-pre-eclamptic women, where regional anesthesia was more frequently used. Our results showed that there was no statistical difference in the proportions of type of anesthesia between pre-eclampsia and non-preeclampsia in both appropriately-grown and growth restricted fetuses. We previously investigated umbilical arterio-venous cord blood gas difference in uncomplicated spontaneous vaginal and non-labor cesarean section w9x. The values of arterio-venous gas differences among cesarean delivery in that study are similar to our result from non-pre-eclamptic growth restricted cases w9x. Although our results were unaffected by the type of anesthesia, it is generally recognized that the type of anesthesia such as general anesthesia at the time of delivery may interfere with the values of umbilical cord blood gases w15x. Therefore, it is potentially explained that our findings may be due to the short-term effect of type of anesthesia. Our study was limited in the sample size and further studies are needed.
The exact mechanism for the difference in placental gas transfer differences between pre-eclamptic and normal women cannot be determined by this study. We can postulate that diffusion distance between the intervillous space and the fetal villous vasculature is increased, perhaps due to increased interstitial edema. Since oxygen is far more prone to diffusion defects, this can explain the decreased arteriovenous oxygen difference. Alternatively, pre-eclamptic women may have villous occlusive disease in the absence of umbilical artery Doppler abnormalities. These could lead to placental perfusion abnormalities as the main cause of altered oxygen capacity. In the absence of correlation with placental ultrastructure evaluation these questions cannot be addressed by this study and certainly open the possibility for further research.
While there were enough cases to do a one-to-one match between pre-eclamptic FGR and non-pre-eclamptic FGR (114 vs. 80 cases, respectively), there were not enough cases to do a one-to-one match between the two groups of AGA (non-pre-eclamptic AGA vs. preeclamptic AGA, 138 vs. 47 cases, respectively). In order to maximize the chance to reflect the crude data values of the cases, we decided to perform a one-to-two match in the study.
In conclusion, umbilical arterial-venous cord blood gas difference, a novel index of placental respiratory function, was successfully applied to pre-eclampsia, demonstrated that pre-eclamptic FGR is significantly associated with a decreased placental oxygenation capacity. This useful placental respiratory function test requires further investigation in various pathologic conditions during pregnancy.
